Designed for controlled laboratory comparison, Tirzepatide is a long-acting peptide agonist at GIP and GLP-1 receptors. Typical study questions concern dual-incretin pharmacology, glucose-dependent islet signaling, appetite pathways, and receptor-balance studies; no clinical outcome is implied.
Designed for controlled laboratory comparison, Tirzepatide is a long-acting peptide agonist at GIP and GLP-1 receptors. Typical study questions concern dual-incretin pharmacology, glucose-dependent islet signaling, appetite pathways, and receptor-balance studies; no clinical outcome is implied.
| Quantity | 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg |
|---|
Reviews
There are no reviews yet.